Role of Fasted Exercise on Improving Cardiometabolic Health

NCT ID: NCT05742373

Last Updated: 2024-03-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this randomised control trial is to investigate the role of fasted exercise on cardiometabolic health. Participants will be assigned to one of three conditions, fasted exercise, fed exercise and control (no exercise). Participants in the exercise groups will complete four weeks of moderate intensity cycling exercise, three times per week, either in the fasted or fed state according to their group assignment. Experimental trials involving anthropometric and cardiometabolic disease risk factor measurements as well as metabolic responses to a subsequent meal ingestion following exercise will be compared pre-intervention and post intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to investigate the effect of fasted exercise on cardiometabolic health and the potential mediatory role of sirtuins.

The objectives are to investigate:

1. The effect of a single bout of fasted exercise on acute metabolic responses following a high fat meal.
2. The effect of four weeks of fasted exercise training on cardiovascular and metabolic disease risk factors.
3. The effect of four weeks of fasted exercise training on circulating levels and subcutaneous adipose tissue gene expression of SIRT1, SIRT3 and SIRT6.

A randomised control trial will be conducted with volunteers allocated under the conditions of a) no exercise (control), b) fasted exercise training (FASTEX) and c) fed exercise training (FEDEX). The pre- and post-intervention visits will consist of 50 minutes of cycling at a moderate exercise intensity for both the FASTEX and FEDEX groups. The control group would not perform any exercise. The FASTEX group will perform the exercise in the fasted state, whilst the FEDEX and control groups will be fed a standardised breakfast meal one hour in advance of the exercise period. Following the exercise period, the participants will be fed a high fat meal and metabolic responses to the meal will be measured for four hours. Multiple blood samples will be obtained as well as a sample of subcutaneous adipose (fat) tissue. The FASTEX and FEDEX groups will then complete four weeks of moderate intensity continuous exercise training, either fasted or fed according to their group, on three days per week whilst the control group will maintain their normal sedentary lifestyle. All participants will return to the laboratory for post-intervention testing at the end of the four weeks with the same protocols and measurements as the pre-intervention testing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases Diabetes Mellitus, Type 2 Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomised control
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fasted exercise

Exercise training in the fasted state

Group Type EXPERIMENTAL

Exercise training in the fasted state

Intervention Type OTHER

Four weeks of moderate intensity cycling exercise, three times a week without eating breakfast meal

Fed exercise

Exercise training in the fed state

Group Type ACTIVE_COMPARATOR

Exercise training in the fed state

Intervention Type OTHER

Four weeks of moderate intensity cycling exercise, three times a week, after eating breakfast meal

Control

No exercise training

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise training in the fasted state

Four weeks of moderate intensity cycling exercise, three times a week without eating breakfast meal

Intervention Type OTHER

Exercise training in the fed state

Four weeks of moderate intensity cycling exercise, three times a week, after eating breakfast meal

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female
* Non-smokers
* Physically inactive (partake in no more than one exercise session per week on average)
* Body mass index \>18.5 kg/m2
* Healthy as assessed by medical screening questionnaire
* Prior recipient of local anaesthetic with no known adverse effects, no known hypersensitivity or no other health issue that may constrain the administration of lidocaine hydrochloride
* Free from musculoskeletal injury and able to perform cycling exercise
* Capacity to give informed consent

Exclusion Criteria

* Regular exerciser
* BMI \< 18.5 kg/m2
* Pregnant
* Allergy or intolerances to test meal products/ingredients (such as wheat or dairy products).
* Recent major body weight change (+/- 3 kg in the past month)
* Known hypersensitivity to Lidocaine Hydrochloride
* Cardiovascular disease - complete heart block or hypovolaemia
* Adam's-Stokes Syndrome
* Wolff-Parkinson-White Syndrome
* Porphyria
* Epilepsy
* Myasthenia Gravis
* Other chronic medical condition or diagnosis including respiratory (eg asthma), endocrine, cardiovascular, neuromuscular disorders.
* Taking medications or receiving treatment that may constrain the administration of lidocaine or local anaesthesia.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Society for Clinical Nutrition and Metabolism

OTHER

Sponsor Role collaborator

Manchester Metropolitan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Adora Yau

Senior Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adora Yau, PhD

Role: PRINCIPAL_INVESTIGATOR

Manchester Metropolitan University

Gethin Evans, PhD

Role: STUDY_DIRECTOR

Manchester Metropolitan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Manchester Metropolitan University

Manchester, Greater Manchester, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Adora Yau, PhD

Role: CONTACT

+44(0)1612475504

Gethin Evans, PhD

Role: CONTACT

+44(0)1612471208

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Adora Yau, PhD

Role: primary

+44(0)1612475504

Gethin Evans, PhD

Role: backup

+44(0)1612471208

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FastExTrainESPEN2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NR Supplementation and Exercise
NCT04907110 COMPLETED NA